Literature DB >> 10480822

What is meant by intention to treat analysis? Survey of published randomised controlled trials.

S Hollis1, F Campbell.   

Abstract

OBJECTIVES: To assess the methodological quality of intention to treat analysis as reported in randomised controlled trials in four large medical journals.
DESIGN: Survey of all reports of randomised controlled trials published in 1997 in the BMJ, Lancet, JAMA, and New England Journal of Medicine. MAIN OUTCOME MEASURES: Methods of dealing with deviations from random allocation and missing data.
RESULTS: 119 (48%) of the reports mentioned intention to treat analysis. Of these, 12 excluded any patients who did not start the allocated intervention and three did not analyse all randomised subjects as allocated. Five reports explicitly stated that there were no deviations from random allocation. The remaining 99 reports seemed to analyse according to random allocation, but only 34 of these explicitly stated this. 89 (75%) trials had some missing data on the primary outcome variable. The methods used to deal with this were generally inadequate, potentially leading to a biased treatment effect. 29 (24%) trials had more than 10% of responses missing for the primary outcome, the methods of handling the missing responses were similar in this subset.
CONCLUSIONS: The intention to treat approach is often inadequately described and inadequately applied. Authors should explicitly describe the handling of deviations from randomised allocation and missing responses and discuss the potential effect of any missing response. Readers should critically assess the validity of reported intention to treat analyses.

Entities:  

Mesh:

Year:  1999        PMID: 10480822      PMCID: PMC28218          DOI: 10.1136/bmj.319.7211.670

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  32 in total

Review 1.  Intention-to-treat analysis: implications for quantitative and qualitative research.

Authors:  D J Newell
Journal:  Int J Epidemiol       Date:  1992-10       Impact factor: 7.196

2.  Improving the quality of reporting of randomized controlled trials. The CONSORT statement.

Authors:  C Begg; M Cho; S Eastwood; R Horton; D Moher; I Olkin; R Pitkin; D Rennie; K F Schulz; D Simel; D F Stroup
Journal:  JAMA       Date:  1996-08-28       Impact factor: 56.272

3.  Analysing non-compliance in clinical trials: ethical imperative or mission impossible?

Authors:  E J Goetghebeur; S H Shapiro
Journal:  Stat Med       Date:  1996-12-30       Impact factor: 2.373

4.  Intent-to-treat analysis for longitudinal studies with drop-outs.

Authors:  R Little; L Yau
Journal:  Biometrics       Date:  1996-12       Impact factor: 2.571

5.  Effect of non-random missing data mechanisms in clinical trials.

Authors:  S C Choi; I L Lu
Journal:  Stat Med       Date:  1995-12-30       Impact factor: 2.373

6.  Blinding and exclusions after allocation in randomised controlled trials: survey of published parallel group trials in obstetrics and gynaecology.

Authors:  K F Schulz; D A Grimes; D G Altman; R J Hayes
Journal:  BMJ       Date:  1996-03-23

7.  Randomised placebo-controlled trial of monthly intravenous immunoglobulin therapy in relapsing-remitting multiple sclerosis. Austrian Immunoglobulin in Multiple Sclerosis Study Group.

Authors:  F Fazekas; F Deisenhammer; S Strasser-Fuchs; G Nahler; B Mamoli
Journal:  Lancet       Date:  1997-03-01       Impact factor: 79.321

8.  Medical Research Council randomised trial of endometrial resection versus hysterectomy in management of menorrhagia.

Authors:  H O'Connor; J A Broadbent; A L Magos; K McPherson
Journal:  Lancet       Date:  1997-03-29       Impact factor: 79.321

9.  The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts.

Authors: 
Journal:  N Engl J Med       Date:  1997-01-16       Impact factor: 91.245

10.  Intention to treat--who should use ITT?

Authors:  J A Lewis; D Machin
Journal:  Br J Cancer       Date:  1993-10       Impact factor: 7.640

View more
  490 in total

1.  Intention to treat analysis is related to methodological quality.

Authors:  M Ruiz-Canela; M A Martínez-González; J de Irala-Estévez
Journal:  BMJ       Date:  2000-04-08

Review 2.  Systematic reviews in health care: Assessing the quality of controlled clinical trials.

Authors:  P Jüni; D G Altman; M Egger
Journal:  BMJ       Date:  2001-07-07

Review 3.  Intention-to-treat principle.

Authors:  V M Montori; G H Guyatt
Journal:  CMAJ       Date:  2001-11-13       Impact factor: 8.262

4.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials.

Authors:  David Moher; Kenneth F Schulz; Douglas G Altman
Journal:  Clin Oral Investig       Date:  2003-01-31       Impact factor: 3.573

5.  Pleasing some of the people none of the time.

Authors:  Paul Hilton; Karen L Ward
Journal:  BMJ       Date:  2002-12-07

6.  Chronic fatigue in general practice: is counselling as good as cognitive behaviour therapy? A UK randomised trial.

Authors:  L Ridsdale; E Godfrey; T Chalder; P Seed; M King; P Wallace; S Wessely
Journal:  Br J Gen Pract       Date:  2001-01       Impact factor: 5.386

7.  An open-label pilot study of the efficacy and safety of anakinra in patients with psoriatic arthritis refractory to or intolerant of methotrexate (MTX).

Authors:  Norma Jung; Matthias Hellmann; Reimund Hoheisel; Clara Lehmann; Ingo Haase; Andreas Perniok; Michael Hallek; Andrea Rubbert
Journal:  Clin Rheumatol       Date:  2010-06-09       Impact factor: 2.980

Review 8.  Evidence for risk of bias in cluster randomised trials: review of recent trials published in three general medical journals.

Authors:  Suezann Puffer; David Torgerson; Judith Watson
Journal:  BMJ       Date:  2003-10-04

9.  A modelling strategy for the analysis of clinical trials with partly missing longitudinal data.

Authors:  Ian R White; Erica Moodie; Simon G Thompson; Tim Croudace
Journal:  Int J Methods Psychiatr Res       Date:  2003       Impact factor: 4.035

Review 10.  Avoidance versus use of neuromuscular blocking agents for improving conditions during tracheal intubation or direct laryngoscopy in adults and adolescents.

Authors:  Lars H Lundstrøm; Christophe Hv Duez; Anders K Nørskov; Charlotte V Rosenstock; Jakob L Thomsen; Ann Merete Møller; Søren Strande; Jørn Wetterslev
Journal:  Cochrane Database Syst Rev       Date:  2017-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.